Closed
Source verified July 31, 2026
MEDTEQ+ — AVISÉ program
Real-world evaluation of innovative Quebec health technologies
Funding available
$ 500,000 - $ 700,000
Deadline
Closed
Location
Quebec, Canada
Who can apply
For-profit businesses or groups of businesses in medical technology or digital health, including AI, legally incorporated under the laws of Quebec or Canada
See full eligibility
Overview
The AVISÉ program provides non-repayable financial support of up to $700,000 to innovative Quebec-based life sciences companies for a real-world evaluation study close to commercialization. It supports projects that demonstrate the value of medical and digital health technologies through collaboration with RÉIS expert evaluation teams.
Find open grants for your business
Explore open funding programs that match your business and project.
At a glance
Funding available
Financing goals
- Increase performance through digital transformation
- Develop strategic partnerships
- Increase production or service capacity
Eligible Funding
- Maximum amount : 700,000 $
- Minimum amount : 500,000 $
- Up to 50% of project cost
Eligible candidates
Eligible Industries
- All industries
Location
- Quebec
Legal structures
- For-profit business
- Social economy enterprise
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- Canadians
- Startups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Evaluation of a new product, technology, or process in the health or medical sector that is near commercialization.
- Assessment of significant improvements to an existing product, technology, or process in healthcare, requiring research and development efforts.
- Projects that demonstrate the overall value and relevance of a health technology to facilitate market access in Quebec, nationally, or internationally.
- Studies conducted in collaboration with expert evaluation teams to test technologies addressing priority needs in areas such as primary care access, patient care pathways, task automation, or robotic surgery.
- Initiatives aiming to validate the commercial potential of a new health innovation, subject to technological or business risk, within an 18-month timeline.
Documents Needed
- The application form completed in French and signed by the company CEO and the CEO or PDGA of the expert evaluator and the evaluation site, if different, in PDF and digital format
- A video of up to 5 minutes presenting the technology in use and explaining how it addresses the priority needs, its overall value, relevance and innovative character
- The pivotal scientific literature related to the technology and the information provided for homologation
- The completed and signed service offer or offers from the evaluation expert
- For projects involving IT resources of an RSSS establishment, a commitment letter from the evaluation site’s TI department director
Eligibility
Who is eligible?
- For-profit businesses or groups of businesses in medical technology or digital health, including AI, legally incorporated under the laws of Quebec or Canada
- Social economy enterprises within the meaning of the Social Economy Act
- Companies run by a founder or founding team, with at least one founder dedicated full-time (35 hours or more per week)
Who is not eligible
- Companies listed temporarily or permanently on the RENA, including subcontractors expected to carry out work on the project
- Companies listed on the francization non-compliance list of the Office québécois de la langue française
- Companies that defaulted on obligations after formal notice within the previous two years in connection with prior Quebec government financial assistance
- State enterprises or companies controlled directly or indirectly by a municipal, provincial or federal government, a municipal entity, or majority-owned by a state enterprise
- Holding companies, companies under bankruptcy or insolvency protection, and companies whose main business is arms, fossil fuels, gambling, violent games or combat sports, sexual exploitation, or tobacco/drug-related activities
Eligible expenses
- Direct labour costs, student scholarships, and materials, consumables and supplies
- Purchase or rental of equipment and travel and accommodation expenses related to the project
- Professional fees for technology evaluation, implementation and use, plus professional and specialized service fees and subcontracting
- Dissemination of results, specialized platforms, studies or other documentation, and monetary compensation for participation
- Project management fees charged by MEDTEQ+ and indirect research costs (FIR)
Ineligible Costs and Activities
- Expenses incurred before the final submission deadline, including committed contractual expenses
- Regular operating expenses of the company and Quebec sales taxes
- Recurring fees, such as annual subscriptions and software update fees
- Capital expenditures and depreciation, sponsorships, debt service, future loan repayment, capital loss or replacement, and capital payments
- IP maintenance and commercialization expenses, and real estate or land acquisition, construction or expansion costs
Eligible geographic areas
- Quebec
Selection criteria
- Innovative character of the technology (maximum 25 points): Presence of a decisive advantage of the product or process compared to existing solutions nationally or internationally. Must obtain at least 80% (20 out of 25) for admissibility.
- Overall value of the innovation and social acceptability (maximum 25 points): Relevance for health systems, potential impact on various levels (population, clinical, organizational, sociocultural, environmental), response to identified priority needs, and social acceptance.
- Feasibility and relevance of the project in relation to the objectives of the call for projects (maximum 25 points): Quality and realism of the implementation plan, schedule and budget, quality of partners, risk management, sustainable development considerations, project pertinence, and risk assessment.
- Company's capacity to carry out the project (maximum 15 points): Alignment with business strategy, track record and key achievements, internal expertise and experience relevant to the project’s requirements.
- Potential benefits for the company and its sector (maximum 10 points): Market potential, business model and go-to-market strategy, commercialization experience, and intellectual property position and strategy.
How to apply
- Request the application form from MEDTEQ+ and book a meeting with a MEDTEQ+ innovation integration manager to verify eligibility and project matching
- Submit the project proposal by email to avise@medteq.ca before the deadline
- Use the subject line Soumission de demande d’aide financière — Nom de votre compagnie and cc the people participating in the project
Processing and Agreement
- Applications are assessed by a Comité d’évaluation composed of external experts, and recommendations are then sent to MEDTEQ+’s board and the MEIE for funding authorization
- MEDTEQ+ informs the companies of the funding decision
- Selected companies must provide their financial statements for the last two years, dated less than six months, as well as financial forecasts and a two-year cash flow projection
- They must sign the MEDTEQ+ funding agreement
- Payments are made as a 25% advance after the agreement is signed and the required authorizations are obtained, a 50% reimbursement after 75% of eligible expenses are incurred, paid and submitted, and a final 25% reimbursement after all eligible expenses are incurred, paid and submitted; progress reports and annual follow-up reports one and two years after project completion are also required
Additional information
- The call for projects guide is only available in French.
Contacts
Frequently Asked Questions about the MEDTEQ+ — AVISÉ program Program
What is the MEDTEQ+ — AVISÉ program?
The AVISÉ program provides non-repayable financial support of up to $700,000 to innovative Quebec-based life sciences companies for a real-world evaluation study close to commercialization. It supports projects that demonstrate the value of medical and digital health technologies through collaboration with RÉIS expert evaluation teams.
How much funding can be received?
MEDTEQ+ — AVISÉ program Funds up to 50% of admissible expenses, capped at $700,000 per project.
Who is eligible for the MEDTEQ+ — AVISÉ program program?
To be eligible for the MEDTEQ+ — AVISÉ program program, you must:
For-profit businesses or groups of businesses in medical technology or digital health, including AI, or social economy enterprises
Companies must be registered in Quebec, have an establishment there, and actively carry on business there
The company must own the rights to use its intellectual property and at least one founder must work full-time
What expenses are eligible under MEDTEQ+ — AVISÉ program?
Evaluation of a new product, technology, or process in the health or medical sector that is near commercialization.
Assessment of significant improvements to an existing product, technology, or process in healthcare, requiring research and development efforts.
Projects that demonstrate the overall value and relevance of a health technology to facilitate market access in Quebec, nationally, or internationally.
Studies conducted in collaboration with expert evaluation teams to test technologies addressing priority needs in areas such as primary care access, patient care pathways, task automation, or robotic surgery.
Initiatives aiming to validate the commercial potential of a new health innovation, subject to technological or business risk, within an 18-month timeline.
Who can I contact for more information about the MEDTEQ+ — AVISÉ program?
You can contact Consortium de recherche et d’innovation en technologies médicales du Québec (MEDTEQ) by email at avise@medteq.ca.
Where is the MEDTEQ+ — AVISÉ program available?
The MEDTEQ+ — AVISÉ program program is available the province of Quebec.
Is the MEDTEQ+ — AVISÉ program a grant, loan, or tax credit?
MEDTEQ+ — AVISÉ program is a Grant and Funding